NATCOPHARM.NS
NATCO Pharma Limited$842.20
Jun 11, 2026
Market cap
$153.46B
52w range
—
P / E
—
EPS · FY 2026
$79.21
Volume
—
Revenue · FY 2026
$40.78B
Explain this page
Arphra AIPlain-English read on NATCO Pharma Limited’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$1,764.59
— vs spot
Recommendation
n/a
3 of 3 methods
Method spread
0bull0bear
±5% threshold
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Utilities+2.58%
- Energy+1.31%
- Basic Materials+0.81%
- Consumer Defensive+0.72%
- Technology+0.67%
- Real Estate+0.47%
- Financial Services+0.33%
- Industrials+0.06%
- Consumer Cyclical-0.34%
- Communication Services-0.77%
- Healthcare-1.62%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - Specialty & Generic-0.53%
- Broadcasting-4.06%
- Coal+3.67%
- Renewable Utilities+3.61%
- Silver+3.21%
- Computer Hardware+2.54%
- Medical - Equipment & Services-2.31%
- Oil & Gas Energy+2.30%
- Auto - Dealerships-2.28%
- Copper+2.24%
- Drug Manufacturers - General-2.21%
- Medical - Healthcare Information Services-2.20%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for NATCOPHARM.NS.
Peers
No peer list available for NATCOPHARM.NS.
Total assets
$110.74B
Total debt
$7.14B
Cash & equiv
$1.99B
Operating CF
$17.68B
Free cash flow
$13.77B
Buybacks
$0
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2026 | $40.78B | $12.3B | $14.19B | $79.21 | +34.78% |